Capsugel, Inc.
 | |
| Private | |
| ISIN | 🆔 |
| Industry | Healthcare |
| Founded 📆 | |
| Founder 👔 | |
| Headquarters 🏙️ | Morristown, New Jersey, U.S. |
Number of locations | 13 facilities (2016)[1] |
Area served 🗺️ | |
Key people | Guido Driesen (President & CEO) |
| Products 📟 | Drug capsules |
| Revenue🤑 | US$750 million (2011)[2] |
| Members | |
Number of employees | 3,600 (2016)[1] |
| Parent | Lonza Group |
| 🌐 Website | capsugel |
| 📇 Address | |
| 📞 telephone | |
Capsugel is a company that manufactures and sells two-piece hard gelatin drug capsules.[3]:703 In 2011, Capsugel was described as "the world's largest maker of hard capsules".[2] Capsugel also sells equipment for filling empty and liquid capsules, as well as equipment for sealing liquid capsules.
History
Capsugel was founded in the 1960s as a division of Parke-Davis.[2] In 1970, Parke-Davis, including Capsugel, was acquired by Warner Lambert, which was acquired by Pfizer in 2000. On 1 August 2011, Pfizer sold Capsugel to global investment firm Kohlberg Kravis Roberts for $2.38 billion.[2][4] In July 2017, the Lonza Group completed the acquisition of Capsugel for $5.5 billion from Kohlberg Kravis Roberts.[1][5]
In 1987, while a subsidiary of Warner Lambert, the firm was one of only five pharmaceutical joint ventures in China, the joint venture firm being Suzhou Capsugel Ltd.[6]
According to one source, Capsugel originated technology for the production of hard shell capsules from starch.[7]
Executive history
Charles Hoover was promoted to President of the company in 1989; he had previously served as the general manager of the company's largest manufacturing facility and had introduced a quality improvement culture to the company starting in 1982.[3]:706-707 During his tenure as President, he introduced a company-wide focus on statistical process control.[3]:707
By 2016, the company's President and chief executive officer (CEO) was Guido Driesen.[1]
Products
At least as of the early 1990s, the company defined customer value in terms of traditional product quality as this was what customers both demanded and needed as the capsule products were faced with increasing degrees of filling automation and filling speed.[3]:802 The product quality metric was a matter of ensuring consistency among batches delivered to the customer.[8]:503 At one point, the company had more than 100 inspectors at every major manufacturing facility to inspect each product twice; over time, cost reductions were realized by major reductions in this inspection crew as statistical process control methods were implemented.[8]:181, 475
Coni-Snap
Coni-Snap capsules are Capsugel's most widely recognized product, a standard two-part hard gelatin capsule that are usually filled with either powder or granules (though they can also be filled with pellets, tablets, pastes, or liquids). Coni-Snap capsules are distributed in multiple sizes and colors.[9]
The body section of the Coni-Snap design has a tapered rim to facilitate encapsulation on high-speed capsule-filling machines. It has a dual snap-ring locking system that provides an initial attachment prior to capsule filling and a final closure of the filled capsule. The Coni-Snap design also includes air vents to avoid unwanted air compression within the capsule during high speed filling.
DBcaps
DBcaps capsules are a line of capsules designed specifically for use in double-blind studies. These opaque capsules are large enough to encapsulate a range of tablet sizes, so splitting or grinding is not required, reducing variability in the study. The DBcap capsule design also incorporates a locking design to prevent the participants from opening the capsules and breaking the blind.[10]
Vcaps
Vcaps capsules are a two-piece capsule made of hydroxypropyl methylcellulose, a cellulose-based raw material. They were designed to meet restrictive dietary needs, and are thus gluten-free, vegan, kosher, and halaal.[11]
Licaps
Licaps capsules are two-piece gelatin or hydroxypropyl methylcellulose capsules designed specifically for containing liquids or semi-solids. Licaps can be used when drugs' ingredients are more stable as a liquid, such as in dietary supplements.[12]
Facilities
As of 1991, the company's four largest manufacturing plants were located in the United States (Greenwood, South Carolina),[3]:709 Belgium, France and Japan; smaller manufacturing units were located in Britain, Mexico, Italy, Thailand, Brazil and China.[3]:704
Intellectual property
European patent EP2844297 "Aqueous Dispersions of Controlled Release Polymers and Shells and Capsules Thereof", filed in 2013, was granted to the Belgium unit of Capsugel in 2018 with an anticipated expiry in 2033.[13][14]
European patent EP2844296 "Aqueous Dispersions of Hydroxypropyl Methylcellulose Acetate Succinate (HPMCAS)", filed in 2013, was granted to the Belgium unit of Capsugel in 2019 with an anticipated expiry in 2033.[15][16]
Notes
- ↑ 1.0 1.1 1.2 1.3 "Lonza to Acquire Capsugel to Create Leading Integrated Solutions Provider to the Global Pharma and Consumer Healthcare Industries". New Jersey Business. Trenton, New Jersey: New Jersey Business & Industry Association. December 15, 2016. Retrieved 21 Jan 2020. Unknown parameter
|url-status=ignored (help) - ↑ 2.0 2.1 2.2 2.3 Krauskopf, Lewis (April 4, 2011). "Pfizer selling Capsugel to KKR for $2.38 billion". Reuters. Archived from the original on 13 January 2020. Retrieved 21 Jan 2020. Unknown parameter
|url-status=ignored (help) - ↑ 3.0 3.1 3.2 3.3 3.4 3.5 Judge W, Stahl MJ, Scott R, Millender R (1991). "Long-term Quality Improvement and Cost Reduction at Capsugel / Warner-Lambert (Chapter 28)". In Stahl MJ, Bounds GM. Competing Globally Through Customer Value. Westport, Connecticut: Quorum Books (Greenwood Publishing Group). ISBN 0-89930-600-4 – via Internet Archive. Search this book on
Note: two of the four authors of Chapter 28 were Capsugel employees. Also cited is "Summary and Implications (Chapter 34), by the editors of the book.
- ↑ Bonds, Shannon; Jack, Andrew (4 April 2011). "KKR to buy Pfizer's capsule unit for $2.4bn". The Financial Times. Unknown parameter
|url-status=ignored (help) - ↑ "Lonza Completes Acquisition of Capsugel to Create Leading Integrated Solutions Provider to the Global Pharma and Consumer Healthcare Industries". Media Center (Press release). Lonza. July 6, 2017. Retrieved 20 Jan 2020.
- ↑ Yi, Xu Bai (1990). Marketing to China: One Billion New Customers. Lincolnwood, Illinois: NTC Business Books (NTC Publishing Group). p. 12. LCCN 89-60187 – via Internet Archive. Search this book on
- ↑ Augsburger, Larry L. (2002). "Hard and Soft Shell Capsules (Chapter 11)". In Banker, Gilbert S.; Rhodes, Christopher T. Modern Pharmaceutics (4th ed.). New York City: Marcel Dekker. ISBN 0-8247-0674-9 – via Internet Archive. Search this book on Note: Source lacks page numbers; the cited item here comes from page 2 of the cited chapter.
- ↑ 8.0 8.1 Stahl, Michael J. (1995). Management: Total Quality in a Global Environment. Cambridge, Massachusetts: Blackwell Business (Basil Blackwell). ISBN 1-55786-610-4 – via Internet Archive. Search this book on Note: This work is a textbook and contains a case study devoted to Capsugel beginning on page 438, entitled "Long-Term Quality Improvement and Cost Reduction at Capsugel/Warner-Lambert". With respect to status as a textbook, the Preface opens with "This book has been designed, written, and produced for students taking their first course in management of organizations."
- ↑ "Coni-Snap Hard Gelatin Capsules". Capsules. Capsugel. Archived from the original on May 27, 2011. Retrieved 28 Dec 2012. Unknown parameter
|url-status=ignored (help)[self-published source] - ↑ "DBcaps Over-encapsulation Capsules". Capsules. Capsugel. Archived from the original on May 27, 2011. Retrieved 28 Dec 2012. Unknown parameter
|url-status=ignored (help)[self-published source] - ↑ "Vcaps & Vcaps Plus Plant-based Capsules". Capsules. Capsugel. Archived from the original on December 26, 2012. Retrieved 28 Dec 2012. Unknown parameter
|url-status=ignored (help)[self-published source] - ↑ "Licaps Liquid-filled Capsules". Capsules. Capsugel. Archived from the original on May 27, 2011. Retrieved 28 Dec 2012. Unknown parameter
|url-status=ignored (help)[self-published source] - ↑ "Global Dossier". US Patent & Trademark Office. EP 13711002. Retrieved 20 Jan 2020. Unknown parameter
|url-status=ignored (help) - ↑ "EP2844297A1 - Aqueous dispersions of controlled release polymers and shells and capsules thereof". Google Patents. Application EP13711002.9A events. Retrieved 20 Jan 2020. Unknown parameter
|url-status=ignored (help) - ↑ "Global Dossier". US Patent & Trademark Office. EP 13709435. Retrieved 20 Jan 2020. Unknown parameter
|url-status=ignored (help) - ↑ "EP2844296A1 - Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas)". Google Patents. Application EP13709435.5A events. Retrieved 20 Jan 2020. Unknown parameter
|url-status=ignored (help)
Further reading
- Hiam, Alexander (1991). "Capsugel Crisis Management Checklist". The Vest-Pocket Marketer. Englewood Cliffs, New Jersey: Prentice-Hall (Simon & Schuster). pp. 295–8. ISBN 0-13-932302-3 – via Internet Archive. Search this book on
- Staff (September 23, 1992). "Casugel Recognizes Tech Partnership". The Newberry Observer. 128 (112). Newberry, South Carolina: Newberry Publishing Company. p. 8 – via Google News. Unknown parameter
|url-status=ignored (help)
External links
This article "Capsugel" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Capsugel. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
|
This page exists already on Wikipedia. |
